secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2023-09-12T23:59:59+00:00
Accession:  0001493152-23-032347
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics stockholders elect directors and approve all proposals at annual meeting
--------------------------------------------------------------------------------

- Four director nominees elected: Hankey, Stroever, Lucera, Angle; broker non-votes of 578,270 for each.
- Advisory vote on executive compensation approved: 904,764 for, 84,094 against, 307,376 abstentions.
- Advisory frequency vote selects every year (958,400 votes); board adopts annual say-on-pay policy.
- Ratification of Weinberg & Company as auditor for FY2023: 1,513,051 for, 61,316 against.
- First Amendment to 2015 Equity Incentive Plan approved: 863,931 for, 123,150 against, 309,153 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223032347/0001493152-23-032347-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223032347/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-032347

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer